Postmenopausal Women with Breast, Endometrial, and Ovarian Cancers Have an Increased Risk for Cardiovascular Conditions prior to Active Endocrine Therapy

Table 2

Prevalence of dyslipidemia among cancer patients.

(%)	Total	Breast cancer	Endometrial cancer	Ovarian cancer	value
Dyslipidemia	6739 (62.8)	4896 (61.3)	919 (66.8)	924 (67.5)	<0.001
Elevated TC	1719 (16.0)	1388 (17.4)	187 (13.6)	144 (10.5)	<0.001
Elevated TG	1526 (14.6)	1199 (15.0)	236 (17.2)	127 (9.3)	<0.001
Elevated LDL-C	780 (7.3)	608 (7.6)	102 (7.4)	70 (5.1)	<0.001
Decreased HDL-C	4730 (44.1)	3249 (40.7)	706 (51.3)	775 (56.6)	<0.001
Elevated TC+elevated TG	479 (4.5)	382 (4.8)	61 (4.4)	36 (2.6)	0.002
Elevated TC+elevated LDL-C	739 (6.9)	579 (7.2)	95 (6.9)	65 (4.7)	0.003
Elevated TC+decreased HDL-C	224 (2.1)	150 (1.9)	38 (2.8)	36 (2.6)	0.034
Elevated TG+elevated LDL-C	217 (2.0)	172 (2.2)	26 (1.9)	19 (1.4)	0.166
Elevated TG+decreased HDL-C	678 (6.3)	484 (6.1)	132 (9.6)	62 (4.5)	<0.001
Elevated LDL-C+decreased HDL-C	126 (1.2)	81 (1.0)	27 (2.0)	18 (1.3)	0.009

HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TC: total cholesterol; TG: triglycerides.